Personal information

lung transplant, ischemia-reperfusion injury, acute lung injury, innate immunity, inflammation, adenosine receptors, oxidative stress, DAMPs, cytokines, ex vivo lung perfusion
United States

Activities

Employment (4)

University of Virginia Health System: Charlottesville, VA, US

2013-07 to present | Professor (with Tenure) (Surgery)
Employment
Source: Self-asserted source
Victor E. Laubach

University of Virginia Health System: Charlottesville, VA, US

2009-07 to 2013-06 | Associate Professor (with Tenure) (Surgery)
Employment
Source: Self-asserted source
Victor E. Laubach

University of Virginia Health System: Charlottesville, VA, US

2003-07 to 2009-06 | Associate Professor (Surgery)
Employment
Source: Self-asserted source
Victor E. Laubach

University of Virginia Health System: Charlottesville, VA, US

1996-03 to 2003-06 | Assistant Professor (Surgery)
Employment
Source: Self-asserted source
Victor E. Laubach

Education and qualifications (3)

Glaxo SmithKline Research and Development Research Triangle Park: Research Triangle Park, NC, US

1993-02-01 to 1996-03-01 | Postdoctoral (Cell Biology)
Education
Source: Self-asserted source
Victor E. Laubach

George Washington University: Washington, DC, US

1985-09-01 to 1993-02-01 | PhD (Genetics)
Education
Source: Self-asserted source
Victor E. Laubach

Pennsylvania State University: University Park, PA, US

1981-09-01 to 1985-05-15 | BS (Biology)
Education
Source: Self-asserted source
Victor E. Laubach

Funding (8)

Pannexin-1 Signaling in Lung Ischemia-Reperfusion Injury

2017-04-01 to 2021-03-31 | Grant
National Heart, Lung, and Blood Institute (Bethesda, US)
GRANT_NUMBER: R01HL133293
Source: Self-asserted source
Victor E. Laubach via DimensionsWizard

Adenosine A2 Receptors and Imaging of Inflammation in Lung Reperfusion Injury

2017-02-01 to 2021-01-31 | Grant
National Heart, Lung, and Blood Institute (Bethesda, US)
GRANT_NUMBER: R01HL130053
Source: Self-asserted source
Victor E. Laubach via DimensionsWizard

Prevention of lung transplant Injury with adenosine 2A receptor agonist

2016-04 to 2021-03 | Grant
National Heart, Lung, and Blood Institute (MD, MD, US)
GRANT_NUMBER: 5R01HL128492-02
Source: Self-asserted source
Victor E. Laubach

Ex vivo perfusion in a lung box for rehabilitation of donor lungs

2013-08-01 to 2018-05-31 | Grant
National Heart, Lung, and Blood Institute (Bethesda, US)
GRANT_NUMBER: 5R01HL119218-03
Source: Self-asserted source
Victor E. Laubach via DimensionsWizard

Attenuation of lung reperfusion injury by adenosine A2A receptor activation

2009-04 to 2011-03 | Grant
Roche Organ Transplant Research Foundation (Meggen, CH)
GRANT_NUMBER:

Research Grant

Source: Self-asserted source
Victor E. Laubach
grade
Preferred source (of 3)‎

Adenosine receptor activation in pulmonary ischemia-reperfusion injury

2008-07-09 to 2013-06-30 | Grant
National Heart, Lung, and Blood Institute (Bethesda, US)
GRANT_NUMBER: 5R01HL092953-04
Source: Self-asserted source
Victor E. Laubach via DimensionsWizard

T cell-mediated lung ischemia-reperfusion injury

2004-07-01 to 2014-05-31 | Grant
National Heart, Lung, and Blood Institute (Bethesda, US)
GRANT_NUMBER: 5R01HL077301-08
Source: Self-asserted source
Victor E. Laubach via DimensionsWizard

Nitric Oxide Regulation of Compensatory Lung Growth

2002-04-01 to 2007-03-31 | Grant
National Heart, Lung, and Blood Institute (Bethesda, US)
GRANT_NUMBER: 5R01HL067780-04
Source: Self-asserted source
Victor E. Laubach via DimensionsWizard